---
figid: PMC6766623__zh20081988490012
figlink: pmc/articles/PMC6766623/figure/F0012/
number: Fig. 12
caption: Model of molecular mechanisms by which pretreatment with monophosphoryl lipid
  A (MPLA) suppresses LPS signaling in the medullary thick ascending limb. LPS inhibits  absorption
  through activation of a basolateral Toll-like receptor 4-myeloid differentiation
  factor 88-IL-1 receptor-associated kinase-1-extracellular signal-regulated kinase
  (TLR4-MyD88-IRAK-1-ERK) pathway (, , ). MPLA activates a TLR4-Toll/IL-1 receptor
  domain-containing adaptor-inducing interferon-β (TRIF)-phosphatidylinositol 3-kinase
  (PI3K)-dependent pathway that increases expression of Toll-interacting protein (Tollip).
  Tollip, in turn, negatively regulates LPS signaling downstream of TLR4-MyD88 by
  suppressing the phosphorylation and activation of IRAK-1. Inhibition of IRAK-1 prevents
  subsequent activation of ERK that mediates LPS inhibition of  absorption (, ). Arrows
  do not necessarily imply direct relationships; regulatory steps may involve additional
  signaling components.
pmcid: PMC6766623
papertitle: Monophosphoryl lipid A induces protection against LPS in medullary thick
  ascending limb through induction of Tollip and negative regulation of IRAK-1.
reftext: Bruns A. Watts, et al. Am J Physiol Renal Physiol. 2019 Sep 1;317(3):F705-F719.
pmc_ranked_result_index: '11370'
pathway_score: 0.9289457
filename: zh20081988490012.jpg
figtitle: Molecular mechanisms by which pretreatment with monophosphoryl lipid A (MPLA)
  suppresses LPS signaling in the medullary thick ascending limb
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6766623__zh20081988490012.html
  '@type': Dataset
  description: Model of molecular mechanisms by which pretreatment with monophosphoryl
    lipid A (MPLA) suppresses LPS signaling in the medullary thick ascending limb.
    LPS inhibits  absorption through activation of a basolateral Toll-like receptor
    4-myeloid differentiation factor 88-IL-1 receptor-associated kinase-1-extracellular
    signal-regulated kinase (TLR4-MyD88-IRAK-1-ERK) pathway (, , ). MPLA activates
    a TLR4-Toll/IL-1 receptor domain-containing adaptor-inducing interferon-β (TRIF)-phosphatidylinositol
    3-kinase (PI3K)-dependent pathway that increases expression of Toll-interacting
    protein (Tollip). Tollip, in turn, negatively regulates LPS signaling downstream
    of TLR4-MyD88 by suppressing the phosphorylation and activation of IRAK-1. Inhibition
    of IRAK-1 prevents subsequent activation of ERK that mediates LPS inhibition of  absorption
    (, ). Arrows do not necessarily imply direct relationships; regulatory steps may
    involve additional signaling components.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRF6
  - TLR4
  - TLR2
  - MYD88
  - IRAK1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - AKT2
  - AKT3
  - AKT1
  - MAP2K1
  - MAP2K2
  - TOLLIP
  - MAPK3
  - MAPK1
  - IHCO3
  - LPS
genes:
- word: LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR2
  symbol: TLR2
  source: hgnc_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: IRAK-1
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Tollip
  symbol: TOLLIP
  source: hgnc_symbol
  hgnc_symbol: TOLLIP
  entrez: '54472'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: IHCO3
  source: MESH
  identifier: C039620
diseases:
- word: LPS
  source: MESH
  identifier: C536528
---
